327 related articles for article (PubMed ID: 8612135)
1. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice.
Haziot A; Ferrero E; Köntgen F; Hijiya N; Yamamoto S; Silver J; Stewart CL; Goyert SM
Immunity; 1996 Apr; 4(4):407-14. PubMed ID: 8612135
[TBL] [Abstract][Full Text] [Related]
2. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice.
Haziot A; Hijiya N; Gangloff SC; Silver J; Goyert SM
J Immunol; 2001 Jan; 166(2):1075-8. PubMed ID: 11145687
[TBL] [Abstract][Full Text] [Related]
3. Divergent response to LPS and bacteria in CD14-deficient murine macrophages.
Moore KJ; Andersson LP; Ingalls RR; Monks BG; Li R; Arnaout MA; Golenbock DT; Freeman MW
J Immunol; 2000 Oct; 165(8):4272-80. PubMed ID: 11035061
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of hepatic CD14 expression between two different endotoxin shock model mice: relation between hepatic injury and CD14 expression.
Hozumi H; Tada R; Murakami T; Adachi Y; Ohno N
PLoS One; 2013; 8(1):e53692. PubMed ID: 23308276
[TBL] [Abstract][Full Text] [Related]
5. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide.
Ferrero E; Jiao D; Tsuberi BZ; Tesio L; Rong GW; Haziot A; Goyert SM
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2380-4. PubMed ID: 7681594
[TBL] [Abstract][Full Text] [Related]
6. Human monocytes lacking the membrane-bound form of the bacterial lipopolysaccharide (LPS) receptor CD14 can mount an LPS-induced oxidative burst response mediated by a soluble form of CD14.
Schütt C; Schilling T; Grunwald U; Stelter F; Witt S; Krüger C; Jack RS
Res Immunol; 1995; 146(6):339-50. PubMed ID: 8719658
[TBL] [Abstract][Full Text] [Related]
7. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production.
Haziot A; Hijiya N; Schultz K; Zhang F; Gangloff SC; Goyert SM
J Immunol; 1999 Apr; 162(8):4801-5. PubMed ID: 10202023
[TBL] [Abstract][Full Text] [Related]
8. Moesin functions as a lipopolysaccharide receptor on human monocytes.
Tohme ZN; Amar S; Van Dyke TE
Infect Immun; 1999 Jul; 67(7):3215-20. PubMed ID: 10377093
[TBL] [Abstract][Full Text] [Related]
9. Reduced early alcohol-induced liver injury in CD14-deficient mice.
Yin M; Bradford BU; Wheeler MD; Uesugi T; Froh M; Goyert SM; Thurman RG
J Immunol; 2001 Apr; 166(7):4737-42. PubMed ID: 11254735
[TBL] [Abstract][Full Text] [Related]
10. CD14 transgenic mice expressing membrane and soluble forms: comparisons of levels of cytokines and lethalities in response to lipopolysaccharide between transgenic and non-transgenic mice.
Tamura Y; Higuchi Y; Kataoka M; Akizuki S; Matsuura K; Yamamoto S
Int Immunol; 1999 Mar; 11(3):333-9. PubMed ID: 10221645
[TBL] [Abstract][Full Text] [Related]
11. CD14 expression on monocytes and TNF alpha production in patients with septic shock, cardiogenic shock or bacterial pneumonia.
de Werra I; Zanetti G; Jaccard C; Chioléro R; Schaller MD; Yersin B; Glauser MP; Calandra T; Heumann D
Swiss Med Wkly; 2001 Jan; 131(3-4):35-40. PubMed ID: 11219189
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta inhibits lipopolysaccharide-stimulated expression of inflammatory cytokines in mouse macrophages through downregulation of activation protein 1 and CD14 receptor expression.
Imai K; Takeshita A; Hanazawa S
Infect Immun; 2000 May; 68(5):2418-23. PubMed ID: 10768925
[TBL] [Abstract][Full Text] [Related]
13. Different efficacy of soluble CD14 treatment in high- and low-dose LPS models.
Stelter F; Witt S; Fürll B; Jack RS; Hartung T; Schütt C
Eur J Clin Invest; 1998 Mar; 28(3):205-13. PubMed ID: 9568466
[TBL] [Abstract][Full Text] [Related]
14. In silico and in vivo approach to elucidate the inflammatory complexity of CD14-deficient mice.
Prince JM; Levy RM; Bartels J; Baratt A; Kane JM; Lagoa C; Rubin J; Day J; Wei J; Fink MP; Goyert SM; Clermont G; Billiar TR; Vodovotz Y
Mol Med; 2006; 12(4-6):88-96. PubMed ID: 16953560
[TBL] [Abstract][Full Text] [Related]
15. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs dysregulated in CD14 gene silencing RAW264.7 macrophage cells.
Du L; Rong H; Cheng Y; Guo S; Shi Q; Jia X; Zhu H; Hao Y; Xu K; Zhang J; Jiao H; Zhao T; Zhang H; Chen C; Wang F
Inflammation; 2014 Feb; 37(1):287-94. PubMed ID: 24062059
[TBL] [Abstract][Full Text] [Related]
17. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses.
Kusunoki T; Hailman E; Juan TS; Lichenstein HS; Wright SD
J Exp Med; 1995 Dec; 182(6):1673-82. PubMed ID: 7500012
[TBL] [Abstract][Full Text] [Related]
18. Human monocyte CD14 is upregulated by lipopolysaccharide.
Landmann R; Knopf HP; Link S; Sansano S; Schumann R; Zimmerli W
Infect Immun; 1996 May; 64(5):1762-9. PubMed ID: 8613389
[TBL] [Abstract][Full Text] [Related]
19. CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction.
Knuefermann P; Nemoto S; Misra A; Nozaki N; Defreitas G; Goyert SM; Carabello BA; Mann DL; Vallejo JG
Circulation; 2002 Nov; 106(20):2608-15. PubMed ID: 12427659
[TBL] [Abstract][Full Text] [Related]
20. The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation.
He Y; Liu S; Kling DE; Leone S; Lawlor NT; Huang Y; Feinberg SB; Hill DR; Newburg DS
Gut; 2016 Jan; 65(1):33-46. PubMed ID: 25431457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
